{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T05:07:52Z","timestamp":1773464872965,"version":"3.50.1"},"reference-count":27,"publisher":"Baishideng Publishing Group Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Exp Med"],"abstract":"<jats:p>A critical work published by Panchannavar et al  on the close link between oral leukoplakia (OLK) and oral squamous cell carcinoma (OSCC), the expression of epithelial mesenchymal transition proteins ZEB1 and E-cadherin would predict the progression of OLK to OSCC. In connection with similar clinical status, there are cumulative data that the urinary bladder leukoplakia (Bladder-LK) progress to invasive bladder squamous cell carcinoma (SCC) which does not response to local therapy that indicates immediate cystectomy, these findings were established with multiple publications with clinical follow-up that showed the progression of leukoplakia to SCC in both oral cavity and urinary bladder. Oral leukoplakia, oral SCC, Bladder-LK, urothelial carcinoma (UC) of the bladder, squamous differentiation of UC, and bladder-SCC showed expression of programmed cell death-ligand 1 (PD-L1). In recent years, immune checkpoint inhibitors immunotherapy for malignant tumors became a promising cancer immunotherapy. However, the role of PD-L1 inhibitors in OLK OSCC is controversial. Objectives are to highlight the rationale for prospective treatment of OLK and OSCC with PD-L1 inhibitors immunotherapy.<\/jats:p>","DOI":"10.5493\/wjem.v16.i1.114526","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T04:30:26Z","timestamp":1773462626000},"source":"Crossref","is-referenced-by-count":0,"title":["Leukoplakia of oral cavity and urinary bladder are premalignant to squamous carcinoma"],"prefix":"10.5493","volume":"16","author":[{"given":"Mohamed","family":"Wishahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.5493\/wjem.v15.i4.110372"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.04.010"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12881"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/odi.14332"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13437"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081840"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11030802"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102748"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/0022034518769645"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1944554"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-025-04023-1"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-17-0108"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-20-0418"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9020194"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1177\/00220345241271992"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cden.2019.08.004"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/odi.13704"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.4853"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/0391560318810197"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/10790268.2007.11753958"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2012.11.020"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115660"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-022-03941-4"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-022-04076-2"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35465"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2020.151640"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-06727-2"}],"container-title":["World Journal of Experimental Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2220-315X\/full\/v16\/i1\/114526.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/2220-315X\/full\/v16\/i1\/114526.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T04:31:22Z","timestamp":1773462682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2220-315X\/full\/v16\/i1\/114526.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":27,"journal-issue":{"issue":"1"},"alternative-id":["114526"],"URL":"https:\/\/doi.org\/10.5493\/wjem.v16.i1.114526","relation":{},"ISSN":["2220-315X"],"issn-type":[{"value":"2220-315X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,20]]}}}